Human cancer cell line microRNAs associated with in vitro sensitivity to paclitaxel

Oncology Reports

Volumn 31, Issue 1, 2014, Pages 376-383

  Chen, Ning ^a   Chon, Hye Sook ^a   Xiong, Yin ^a   Marchion, Douglas C ^a   Judson, Patricia L ^a   Hakam, Ardeshir ^a   Gonzalez Bosquet, Jesus ^a   Permuth Wey, Jennifer ^a   Wenham, Robert M ^a   Apte, Sachin M ^a   Cheng, Jin Q ^a   Sellers, Thomas A ^a   Lancaster, Johnathan M ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Cancer; Chemosensitivity; microRNA; NCI60

Indexed keywords

MICRORNA; PACLITAXEL; PROTEIN MIR 30A 5P; PROTEIN MIR 367; RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL SELECTION; DRUG SENSITIVITY; DRUG TARGETING; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; OVARY CANCER; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; RNA ANALYSIS;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; OVARIAN NEOPLASMS; PACLITAXEL; RNA, MESSENGER; TRANSFECTION;

EID: 84891943977     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2847     Document Type: Article

References (46)

1. Wani MC, Taylor HL, Wall ME, Coggon P and McPhail AT: Plant antitumor agents. VI. The isolation and structure of Taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 93: 2325-2327, 1971.
2. Schiff PB and Horwitz SB: Taxol assembles tubulin in the absence of exogenous guanosine 5′-triphosphate or microtubule-associated proteins. Biochemistry 20: 3247-3252, 1981.
3. Schiff PB and Horwitz SB: Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci USA 77: 1561-1565, 1980.
4. Lim LP, Lau NC, Garrett-Engele P, et al: Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433: 769-773, 2005.
5. Cummins JM and Velculescu VE: Implications of micro-RNA profiling for cancer diagnosis. Oncogene 25: 6220-6227, 2006.
6. He H, Jazdzewski K, Li W, et al: The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA 102: 19075-19080, 2005.
7. Lu J, Getz G, Miska EA, et al: MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005.
8. Chen CZ: MicroRNAs as oncogenes and tumor suppressors. N Engl J Med 353: 1768-1771, 2005.
9. Hwang HW and Mendell JT: MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 94: 776-780, 2006.
10. Johnson SM, Grosshans H, Shingara J, et al: RAS is regulated by the let-7 microRNA family. Cell 120: 635-647, 2005.
11. Corney DC, Flesken-Nikitin A, Godwin AK, Wang W and Nikitin AY: MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res 67: 8433-8438, 2007.
12. Chang TC, Wentzel EA, Kent OA, et al: Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26: 745-752, 2007.
13. Debernardi S, Skoulakis S, Molloy G, Chaplin T, Dixon-McIver A and Young BD: MicroRNA miR-181a correlates with morpho logical sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis. Leukemia 21: 912-916, 2007.
14. Blower PE, Chung JH, Verducci JS, et al: MicroRNAs modulate the chemosensitivity of tumor cells. Mol Cancer Ther 7: 1-9, 2008.
15. Zheng T, Wang J, Chen X and Liu L: Role of microRNA in anticancer drug resistance. Int J Cancer 126: 2-10, 2010.
16. Boren T, Xiong Y, Hakam A, et al: MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy. Gynecol Oncol 113: 249-255, 2009.
17. Zheng A, Kallio A and Harkonen P: Tamoxifen-induced rapid death of MCF-7 breast cancer cells is mediated via extracellu larly signal-regulated kinase signaling and can be abrogated by estrogen. Endocrinology 148: 2764-2777, 2007.
18. Ritchie ME, Silver J, Oshlack A, et al : A comparison of background correction methods for two-colour microarrays. Bioinformatics 23: 2700-2707, 2007.
19. Smyth GK and Speed T: Normalization of cDNA microarray data. Methods 31: 265-273, 2003.
20. Tusher VG, Tibshirani R and Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121, 2001.
21. Bar M, Wyman SK, Fritz BR, et al: MicroRNA discovery and profiling in human embryonic stem cells by deep sequencing of small RNA libraries. Stem Cells 26: 2496-2505, 2008.
22. Wang X and El Naqa IM: Prediction of both conserved and nonconserved microRNA targets in animals. Bioinformatics 24: 325-332, 2008.
23. Sontheimer EJ and Carthew RW: Silence from within: endogenous siRNAs and miRNAs. Cell 122: 9-12, 2005.
24. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV and Mendell JT: c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435: 839-843, 2005.
25. Blower PE, Verducci JS, Lin S, et al: MicroRNA expression profiles for the NCI-60 cancer cell panel. Mol Cancer Ther 6: 1483-1491, 2007.
26. Cittelly DM, Dimitrova I, Howe EN, et al : Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel. Mol Cancer Ther 11: 2556-2565, 2012.
27. Chen Y, Zuo J, Liu Y, Gao H and Liu W: Inhibitory effects of miRNA-200c on chemotherapy-resistance and cell proliferation of gastric cancer SGC7901/DDP cells. Chin J Cancer 29: 1006-1011, 2010.
28. Fujita Y, Kojima K, Ohhashi R, et al: MiR-148a attenuates paclitaxel resistance of hormone-refractory, drug-resistant prostate cancer PC3 cells by regulating MSK1 expression. J Biol Chem 285: 19076-19084, 2010.
29. Du L, Subauste MC, DeSevo C, et al: miR-337-3p and its targets STAT3 and RAP1A modulate taxane sensitivity in non-small cell lung cancers. PLoS One 7: e39167, 2012.
30. Catuogno S, Cerchia L, Romano G, Pognonec P, Condorelli G and de Franciscis V: miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis. Oncogene 32: 341-351, 2013.
31. Holleman A, Chung I, Olsen RR, et al: miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo. Oncogene 30: 4386-4398, 2011.
32. Li J, Zhang Y, Zhao J, Kong F and Chen Y: Overexpression of miR-22 reverses paclitaxel-induced chemoresistance through activation of PTEN signaling in p53-mutated colon cancer cells. Mol Cell Biochem 357: 31-38, 2011.
33. Zhou M, Liu Z, Zhao Y, et al: MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression. J Biol Chem 285: 21496-21507, 2010.
34. Mei M, Ren Y, Zhou X, et al: Downregulation of miR-21 enhances chemotherapeutic effect of taxol in breast carcinoma cells. Technol Cancer Res Treat 9: 77-86, 2010.
35. Huang YW, Liu JC, Deatherage DE, et al: Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 oncogene in endometrial cancer. Cancer Res 69: 9038-9046, 2009.
36. Mialon A, Sankinen M, Soderstrom H, et al: DNA topoisomerase I is a cofactor for c-Jun in the regulation of epidermal growth factor receptor expression and cancer cell proliferation. Mol Cell Biol 25: 5040-5051, 2005.
37. Barroso-delJesus A, Romero-Lopez C, Lucena-Aguilar G, et al: Embryonic stem cell-specific miR302-367 cluster: human gene structure and functional characterization of its core promoter. Mol Cell Biol 28: 6609-6619, 2008.
38. Lavon I, Zrihan D, Granit A, et al: Gliomas display a microRNA expression profile reminiscent of neural precursor cells. Neuro Oncol 12: 422-433, 2010.
39. Sokilde R, Kaczkowski B, Podolska A, et al: Global microRNA analysis of the NCI-60 cancer cell panel. Mol Cancer Ther 10: 375-384, 2011.
40. Greither T, Grochola LF, Udelnow A, Lautenschlager C, Wurl P and Taubert H: Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int J Cancer 126: 73-80, 2010.
41. Levati L, Alvino E, Pagani E, et al: Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155. Int J Oncol 35: 393-400, 2009.
42. Pan X, Zhao J, Zhang WN, et al: Induction of SOX4 by DNA damage is critical for p53 stabilization and function. Proc Natl Acad Sci USA 106: 3788-3793, 2009.
43. Baraniskin A, Birkenkamp-Demtroder K, Maghnouj A, et al: MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL. Carcinogenesis 33: 732-739, 2012.
44. Yanaihara N, Caplen N, Bowman E, et al: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198, 2006.
45. Marchini S, Cavalieri D, Fruscio R, et al: Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections. Lancet Oncol 12: 273-285, 2011.
46. Li X, Zhang Y, Zhang Y, Ding J, Wu K and Fan D: Survival prediction of gastric cancer by a seven-microRNA signature. Gut 59: 579-585, 2010.